Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
tags : Vaccine entities : Nrx pharmaceuticals inc save search
NRx Reports Remarks by Israel Institute for Biological Research on the future of the BriLife™ Covid-19 Investigational Vaccine
Published: 2022-02-11 (Crawled : 13:30) - globenewswire.com
NRXP | News 0 d | $4.17 -3.02% -3.12% 91K
|
Manufacturing
|
| O: -0.93%
H: 0.0%
C: 0.0%
covid-19 israel ema research covid report vaccine brilife
NRx Announces Publication of Initial Findings of BriLife® Vaccine-produced Antibodies Against Omicron Variant
Published: 2022-01-27 (Crawled : 13:00) - biospace.com/
NRXP | News 0 d | $4.17 -3.02% -3.12% 91K
|
Manufacturing
|
| O: 4.43%
H: 0.0%
C: -10.2%
brilife vaccine antibody
NRx Announces Planned Study Investigating BriLife™ Booster Vaccine Against Omicron Variant
Published: 2022-01-11 (Crawled : 15:00) - biospace.com/
NRXP | News 0 d | $4.17 -3.02% -3.12% 91K
|
Manufacturing
|
| O: -2.41%
H: 0.0%
C: 0.0%
vaccine
NRx Pharmaceuticals to Announce New Details for Planned Investigational BriLife™ COVID-19 Vaccine
Published: 2022-01-07 (Crawled : 23:00) - globenewswire.com
NRXP | News 0 d | $4.17 -3.02% -3.12% 91K
|
Manufacturing
| Email alert
Add to watchlist
covid-19 als covid vaccine brilife
NRx Pharmaceuticals and Hungarian Health Officials Agree on Pathway for ZYESAMI® and BriLife COVID-19 Vaccine Trials
Published: 2021-12-09 (Crawled : 14:30) - globenewswire.com
NRXP | News 0 d | $4.17 -3.02% -3.12% 91K
|
Manufacturing
|
| O: 0.67%
H: 5.85%
C: -3.34%
covid-19 zyesami health trials trial covid vaccine brilife
NRx Announces Completion of Data Safety Meeting for Phase 2 Trial of BriLife Vaccine, Phase 2b/3 Registration Trial to Begin in Nation of Georgia, Israel, European Union, and Other Regions
Published: 2021-12-06 (Crawled : 14:30) - globenewswire.com
NRXP | News 0 d | $4.17 -3.02% -3.12% 91K
|
Manufacturing
|
| O: -1.09%
H: 0.0%
C: 0.0%
israel phase 2 europe phase 2b trial vaccine brilife
NRx Pharmaceuticals Notes New Data on BriLife® COVID-19 Vaccine Effectiveness Against Delta Variant Posted by Israel Institute for Biological Research
Published: 2021-11-26 (Crawled : 15:30) - globenewswire.com
NRXP | News 0 d | $4.17 -3.02% -3.12% 91K
|
Manufacturing
|
| O: 2.44%
H: 0.0%
C: 0.0%
brilife covid israel vaccine research
Participants in High Dose BriLife™ Investigational Vaccine Trial for COVID-19 Advised Booster Not Necessary
Published: 2021-08-23 (Crawled : 14:00) - prnewswire.com
NRXP | News 0 d | $4.17 -3.02% -3.12% 91K
|
Manufacturing
|
| O: 0.25%
H: 16.83%
C: 15.41%
covid vaccine trial covid-19
NRx Pharmaceuticals Announces Initiation of Phase 2b Trial of BriLife™ Vaccine for Covid-19 in Nation of Georgia
Published: 2021-08-09 (Crawled : 18:00) - biospace.com/
NRXP | News 0 d | $4.17 -3.02% -3.12% 91K
|
Manufacturing
|
| O: 2.69%
H: 15.8%
C: 11.98%
covid phase 2 vaccine phase 2b trial
NRx Pharmaceuticals Announces Partnership with the Israel Institute for Biological Research to Complete Development and Commercialization of BriLife™ COVID Vaccine
Published: 2021-07-12 (Crawled : 15:15) - prnewswire.com
NRXP | News 0 d | $4.17 -3.02% -3.12% 91K
|
Manufacturing
|
| O: -2.09%
H: 31.85%
C: -14.37%
URGN | $14.27 -1.52% -1.54% 180K
|
Health Technology
|
| O: -0.74%
H: 0.74%
C: 0.2%
PYPD | $4.45 3.29% 1.1K
|
Health Technology
|
| O: 4.35%
H: 0.0%
C: -4.5%
GILD | $66.94 -0.55% -0.55% 5.3M
|
Health Technology
|
| O: 0.93%
H: 1.22%
C: -0.23%
GLMD | $0.336 -5.17% -5.57% 46K
|
Health Technology
|
| O: 0.69%
H: 0.0%
C: -2.74%
covid israel partnership commercialization vaccine research
NRx Pharmaceuticals to Lead Development of COVID-19 Medicines and Vaccines in Central Europe and the Caucasus Region in Collaboration with the Lugar Institute and Cromos Pharma
Published: 2021-05-26 (Crawled : 15:15) - biospace.com/
NRXP | News 0 d | $4.17 -3.02% -3.12% 91K
|
Manufacturing
|
| O: 0.38%
H: 0.0%
C: -6.38%
covid europe collaboration vaccine
Gainers vs Losers
| 56% | 44% |
Top 10 Gainers
INVO | $1.76 131.58% 56.82% 230M
|
Health Technology
SINT | $0.0365 59.39% 37.26% 470M
|
Health Technology
WISA 4 | $9.19 50.66% 33.7% 65M
|
Electronic Technology
EDBL | News | $6.73 47.91% 32.39% 13M
|
GCTK | $0.715 36.27% 26.62% 640K
|
Manufacturing
TCON | $2.33 36.26% 26.61% 2M
|
Health Technology
TIRX | $0.48 6.43% 24.58% 4.8M
|
KZIA | $0.38 30.58% 23.42% 300K
|
Health Technology
VNDA | News | $5.23 29.14% 22.56% 24M
|
Health Technology
ATNF | $1.91 29.05% 22.51% 310K
|
Your saved searches
Save your searches and get alerts when important news are released.